{
    "id": 20802,
    "fullName": "MTOR over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "MTOR over exp indicates an over expression of the Mtor protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "over exp",
    "createDate": "04/06/2016",
    "updateDate": "11/04/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5568,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, pancreatic cancer cells over expressing Mtor were resistant to treatment with Glucophage (metformin) in culture, resulting in cell growth inhibition (PMID: 26760500).",
            "molecularProfile": {
                "id": 21287,
                "profileName": "MTOR over exp"
            },
            "therapy": {
                "id": 1031,
                "therapyName": "Metformin",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 5109,
                    "pubMedId": 26760500,
                    "title": "Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26760500"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 5569,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Glucophage (metformin) with Rapamune (sirolimus) did not result in a synergistic effect when treating pancreatic cancer cells over expressing Mtor (PMID: 26760500).",
            "molecularProfile": {
                "id": 21287,
                "profileName": "MTOR over exp"
            },
            "therapy": {
                "id": 1593,
                "therapyName": "Metformin + Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 5109,
                    "pubMedId": 26760500,
                    "title": "Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26760500"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10038,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sutent (sunitinib) treatment enhanced metastasis of tumors demonstrating innate resistance to Sutent (sunitinib) in allograft models of breast cancer, in which upregulation of Mtor was identified (PMID: 28011623).",
            "molecularProfile": {
                "id": 21287,
                "profileName": "MTOR over exp"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 7922,
                    "pubMedId": 28011623,
                    "title": "Sunitinib Treatment Enhances Metastasis of Innately Drug-Resistant Breast Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28011623"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 21287,
            "profileName": "MTOR over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}